Racial differences in endotoxin-induced tissue factor-triggered coagulation

被引:30
作者
Mayr, F. B. [1 ,4 ]
Spiel, A. O. [1 ]
Leitner, J. M. [1 ]
Firbas, C. [1 ]
Jilma-Stohlawetz, P. [2 ]
Chang, J. -Y. [3 ]
Key, N. S. [3 ]
Jilma, B. [1 ,5 ]
机构
[1] Med Univ Vienna, Dept Clin Pharmacol, A-1090 Vienna, Austria
[2] Med Univ Vienna, Dept Blood Grp Serol & Transfus Med, A-1090 Vienna, Austria
[3] Univ N Carolina, Div Hematol Oncol & Transplantat, Chapel Hill, NC USA
[4] Univ Pittsburgh, Sch Med, Dept Crit Care Med, CRISMA Lab, Pittsburgh, PA USA
[5] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA
关键词
coagulation; Duffy antigen; endotoxin; MCP-1; tissue factor; DUFFY ANTIGEN; INFLAMMATION; ACTIVATION; INHIBITOR; HUMANS; CELLS; PHARMACODYNAMICS; FIBRINOLYSIS; POLYMORPHISM; EXPRESSION;
D O I
10.1111/j.1538-7836.2009.03307.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Racial differences in coagulation are poorly understood. While some studies suggest a 'prothrombotic' coagulation profile in blacks compared with whites, others report an increased bleeding risk for blacks in various clinical settings. Moreover, preclinical data suggest a link between the Duffy antigen (= DARC, Duffy antigen receptor of chemokines) and coagulation. Objectives: Based on our previous research in Duffy antigen negative Africans, we hypothesized that Africans have an attenuated procoagulant response compared with Caucasians in a model of lipopolysaccharide (LPS)-induced, tissue factor (TF)-triggered coagulation activation. Patients/methods: Healthy male volunteers (16 Duffy-negative Africans, 16 Duffy-positive Caucasians) received 2 ng kg(-1) LPS, and outcome parameters were measured using enzyme immunoassays and real-time polymerase chain reaction (RT-PCR, Taqman). Results: LPS increased microparticle (MP)-associated TF procoagulant activity (PCA) less in Africans than Caucasians. Africans had reduced in vivo thrombin formation compared with Caucasians: they generated less thrombin-antithrombin (TAT) complexes (10.4 pg mL(-1) vs. 23.0 pg mL(-1), P < 0.0001) and less prothrombin fragments (F1+2) (337 pmol mL(-1) vs. 819 pmol mL(-1), P < 0.0001). Consistently, Africans also had decreased fibrin formation (d-dimer: 0.3 pg mL(-1) vs. 0.5 pg mL(-1), P = 0.02). Conclusion: Duffy-negative subjects of African descent have a markedly reduced procoagulant response in a model of LPS-induced, TF-triggered coagulation activation compared with Duffy-positive healthy Caucasians.
引用
收藏
页码:634 / 640
页数:7
相关论文
共 30 条
[1]   Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia [J].
Aras, O ;
Shet, A ;
Bach, RR ;
Hysjulien, JL ;
Slungaard, A ;
Hebbel, RP ;
Escolar, G ;
Jilma, B ;
Key, NS .
BLOOD, 2004, 103 (12) :4545-4553
[2]   Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction [J].
Berkowitz, SD ;
Granger, CB ;
Peiper, KS ;
Lee, KL ;
Gore, JM ;
Simoons, M ;
Armstrong, PW ;
Topol, EJ ;
Califf, RM .
CIRCULATION, 1997, 95 (11) :2508-2516
[3]  
CHAUDHURI A, 1994, J BIOL CHEM, V269, P7835
[4]   Issues in minority health: Atherosclerosis and coronary heart disease in African Americans [J].
Clark, LT .
MEDICAL CLINICS OF NORTH AMERICA, 2005, 89 (05) :977-+
[5]   Racial differences in microbleed prevalence in primary intracerebral hemorrhage [J].
Copenhaver, B. R. ;
Hsia, A. W. ;
Merino, J. G. ;
Burgess, R. E. ;
Fifi, J. T. ;
Davis, L. ;
Warach, S. ;
Kidwell, C. S. .
NEUROLOGY, 2008, 71 (15) :1176-1182
[6]   Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia [J].
de Jonge, E ;
Dekkers, PEP ;
Creasey, AA ;
Hack, CE ;
Paulson, SK ;
Karim, A ;
Kesecioglu, J ;
Levi, M ;
van Deventer, SJH ;
van der Poll, T .
BLOOD, 2000, 95 (04) :1124-1129
[7]   Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia [J].
Derhaschnig, U ;
Reiter, R ;
Knöbl, P ;
Baumgartner, M ;
Keen, P ;
Jilma, B .
BLOOD, 2003, 102 (06) :2093-2098
[8]   Variable inhibition of high-shear-induced platelet plug formation by eptifibatide and tirofiban under conditions of platelet activation and high von Willebrand release: A randomized, placebo-controlled, clinical trial [J].
Derhaschnig, U ;
Pachinger, C ;
Jilma, B .
AMERICAN HEART JOURNAL, 2004, 147 (04) :697
[9]   Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia [J].
Derhaschnig, U ;
Bergmair, D ;
Marsik, C ;
Schlifke, I ;
Wijdenes, J ;
Jilma, B .
CRITICAL CARE MEDICINE, 2004, 32 (05) :1136-1140
[10]   The relationship between inflammation and venous thrombosis - A systematic review of clinical studies [J].
Fox, EA ;
Kahn, SR .
THROMBOSIS AND HAEMOSTASIS, 2005, 94 (02) :362-365